dalteparin has been researched along with Skin Diseases, Vascular in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Skin Diseases, Vascular: Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miguélez, A | 1 |
| Barrientos, N | 1 |
| López-Ríos, F | 1 |
| Vanaclocha, F | 1 |
| Iglesias, L | 1 |
1 other study available for dalteparin and Skin Diseases, Vascular
| Article | Year |
|---|---|
Necrotic livedo reticularis, multiple cholesterol emboli and ANCA.
Topics: Abdomen; Aged; Buttocks; Diagnosis, Differential; Embolism, Cholesterol; Enoxaparin; Humans; Hyperch | 2003 |